Skip to search formSkip to main contentSkip to account menu

CGP 9000

Known as: CGP-9000 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cefroxadine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis
SummaryThe pharmacokinetics of cefroxadine was studied in 17 patients with terminal renal impairment, 10 of whom were undergoing… 
1981
1981
[Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)].
CGP 9000 (cefroxadine), a new cephalosporine derived from N-acyl-3-alkoxy-7-amino-3-cefem-4-carboxylic acid for exclusively oral… 
1980
1980
Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers.
Oral doses of 125, 250, and 500 mg of a new cephalosporin, CGP 9000 (7 beta-[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3… 
1980
1980
Cefroxadine (CGP-9000), an orally active cephalosporin
Cefroxadine (GCP-9000; CXD), 7 beta[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3-methoxy-ceph-3-em-carboxylic acid, is a new… 
1980
1980
Cinoxacinの一般薬理作用 (2):循環器系および平滑筋に対する作用
1980
1980
Cefroxadine (CGP-9000) による皮膚感染症の治療成績
1980
1980
Cefroxadine (CGP-9000) にかんする臨床的研究
1980
1980
耳鼻咽喉科領域におけるCefroxadine (CGP-9000) の基礎的ならびに臨床的研究
1978
1978
In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.
The activity against Escherichia coli of a new oral cephalosporin (manufacturer's code: CGP 9000) has been evaluated in vitro… 
1976
1976
CGP 9000: a new orally active, broad-spectrum cephalosporin.
CGP 9000, (7-[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3-methoxy-3-cephem-4-carboxylic acid), is a new broad-spectrum… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)